Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Access to the study page NCT02365766 now returns a 403 Forbidden error, displaying a standard error page instead of the study content.
    Difference
    22%
    Check dated 2026-09-20T00:56:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing v3.6.5. This indicates a system or template update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-29T20:07:56.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision indicator was updated to Revision: v3.6.5. Several legacy sponsor, collaborator, and study document references were removed, resulting in a leaner Study Details page while preserving essential trial information.
    Difference
    20%
    Check dated 2026-08-08T19:26:54.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's metadata. This reflects an update to the page's revision history rather than study content.
    Difference
    0.0%
    Check dated 2026-07-25T10:52:18.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the study record (likely QC or formatting adjustments) without substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-03T21:51:52.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page gains new study metadata and documentation, including sponsor and investigators, collaborators, and links to the Study Protocol and SAP, as well as IPD sharing information and related MeSH terms.
    Difference
    73%
    Check dated 2026-06-26T22:50:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.